The DOI matches its Crossref record.
Ovarian atypical endometriosis: its close association with malignant epithelial tumours
Abstract
The incidence of ovarian atypical endometriosis and its association with malignant epithelial tumours in a consecutive series of cases during the period 1987 to 1995 were studied. Atypical glandular changes were observed in four (1.7%) of 255 ovarian endometriosis cases and one patient with ovarian atypical endometriosis developed subsequent endometrioid carcinoma in the abdominal wall. Fifty-four (24.1%) of the 224 ovarian cancers were associated with ovarian endometriosis; 21 with typical and 33 with atypical endometriosis. Clear cell carcinomas and endometrioid carcinomas were most frequently associated with endometriosis, with 54% (27 of 50 cases) and 41.9% (13 of 31), respectively. Atypical endometriosis was found in 18 clear cell carcinomas, in seven endometrioid carcinomas, in four serous carcinomas, in three mucinous borderline tumours, and in one serous borderline tumour. In 13 cases, the atypical endometriosis was in contiguity with malignant epithelial tumours. We consider that atypical endometriosis possesses a precancerous potential or is most frequently associated with clear cell and endometrioid carcinomas. Close screening of cellular atypia or hyperplasia in ovarian endometriosis and careful long-term follow-up of patients with atypical endometriosis is required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the reasons is that 14.7 to 22.8% of ovarian carcinomas coexist with atypical endometriosis [13,14].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [13]
Citations
Cited by
Sorted by citations
Items 201–300 of 336
Casey, M. J., Bewtra, C., Lynch, H. T., Snyder, C., Stacy, M., & Watson, P. A. (2013) · Familial Cancer · doi:10.1007/s10689-013-9651-x · Cited by 13
Endometriosis and ovarian cancer: Their association and relationship
Esteve, E. B., Pérez-Arguedas, M., Muratori, G. A. G., Acién, M., & Acién, P. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2019.100053 · Cited by 13
Non-neoplastic diseases of the ovary: selected topics
Rollason, T. P. (2002) · Current Diagnostic Pathology · doi:10.1054/cdip.2002.0114 · Cited by 12
Kobayashi, H. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11978 · Cited by 13
Malignant neoplasia arising from ovarian remnants following bilateral salpingo-oophorectomy (Review)
Imai, A., Matsunami, K., Takagi, H., & Ichigo, S. (2014) · Oncology Letters · doi:10.3892/ol.2014.2089 · Cited by 11
“The incidence of endometriosis in females with ovarian cancer is between 8 and 30% (5,18,19).”
Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis
Zhang, C., Wang, X., Anaya, Y., Parodi, L., Cheng, L., Anderson, M. L., & Hawkins, S. M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31768 · Cited by 12
Tomohiro, M., Matsumoto, T., Miura, R., Oguri, Y., Yokoi, A., Tochimoto, M., & Saegusa, M. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.04.001 · Cited by 12
Kato, N. (2020) · Pathology International · doi:10.1111/pin.12954 · Cited by 10
Houghton, O. P., & McCluggage, W. G. (2011) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2011.01.001 · Cited by 9
Nonserous Ovarian Epithelial Tumors
Han, G., & Soslow, R. A. (2011) · Surgical pathology clinics · doi:10.1016/j.path.2010.12.012 · Cited by 9
Transformation maligne postménopausique d’une endométriose extragénitale. À propos d’un cas
Fat, B. C., Terzibachian, J.-J., Govyadovskiy, A., & Grisey, A. (2008) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2007.06.019 · Cited by 9
Yamamoto, S., Tsuda, H., Miyai, K., Takano, M., Tamai, S., & Matsubara, O. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0844-5 · Cited by 9
Clear cell adenocarcinoma of the ovary arising in atypical endometriosis: a report of eight cases
Terada, T. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1929-3 · Cited by 9
“In addition, they demonstrated that atypical endometriosis was in contiguity with CCAO [ 7 ].”
BackgroundResultInfluentialElevated RON protein expression in endometriosis and disease-associated ovarian cancers
Xu, P., Ding, S., Zhu, L., et al. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4248-x · Cited by 9
Ovarian atypical endometriosis
Seidman (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.0285b.x · Cited by 9
Immune pathway through endometriosis to ovarian cancer
Calmon, M. S., Lemos, F. F. B., Luz, M. S., Pinheiro, S. L. R., Silva, L. G. D. O., Santos, G. L. C., Rocha, G. R., & de Melo, F. F. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i4.496 · Cited by 10
Ovarian Clear Cell Carcinoma Arising in a Mucinous Cystadenoma
Wani, Y., & Notohara, K. (2009) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181a934b9 · Cited by 8
“Considering (1) the appearance of a unilocular cyst without any solid mass, (2) the existence of adenofibromatous clear cell elements with distinctively invasive foci of CC, and (3) a histologic continuum between clear and mucinous components, this case was concluded to be an early manifestation of ovarian CC arising…”
BackgroundEvidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer
Carmen, M. G. D. (2015) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000218 · Cited by 8
Komiyama, S., Aoki, D., Katsuki, Y., & Nozawa, S. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.11.030 · Cited by 8
“According to several authors, endometriosis is associated with ovarian clear cell adenocarcinoma in 20–50% of patients, while the rate for serous adenocarcinoma is approximately 3% [11,21,22], a dramatic difference.”
BackgroundRol patogénico del gen supresor de tumores PTEN en cáncer ovárico asociado a endometriosis
Adriana Castiblanco, G., Yumay Pires, N., Wistuba, I. I., et al. (2006) · Revista médica de Chile · doi:10.4067/s0034-98872006000300001 · Cited by 8
Malignancies Associated with Extraovarian Endometriosis: A Literature Review
Inoue, N., Hirakawa, T., Mitsushita, J., Kitahara, Y., & Iwase, A. (2021) · Endocrines · doi:10.3390/endocrines2030024 · Cited by 7
“8% of ovarian carcinomas coexist with atypical endometriosis [13,14].”
BackgroundVoigt, P. C., Chaudhari, A., Tsai, S., Milad, M. P., & Yang, L. C. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001043 · Cited by 7
Ovarian cancer-associated polymorphisms in the BNC2 gene among women with endometriosis
Sundqvist, J., Falconer, H., Seddighzadeh, M., Vodolazkaia, A., Fassbender, A., Kyama, C. M., Bokor, A., Stephansson, O., Gemzell‐Danielsson, K., & D’Hooghe, T. (2011) · Human Reproduction · doi:10.1093/humrep/der169 · Cited by 7
Clear Cell Adenocarcinoma Arising from Adenofibroma in a Patient with Endometriosis of the Ovary
Cho, I., & Lim, S. (2015) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2015.08.07 · Cited by 7
Three cases of clear‐cell adenocarcinoma arising from endometrioma during hormonal treatments
Yoshino, O., Minamisaka, T., Ono, Y., Tsuda, S., Samejima, A., Shima, T., Nakashima, A., Koga, K., Osuga, Y., & Saito, S. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13702 · Cited by 8
Is ovarian cystectomy for atypical ovarian endometrioma safe?: A single center study
Kim, J. M., & Hong, D. G. (2022) · Medicine · doi:10.1097/md.0000000000030272 · Cited by 6
“However, Fukunaga et al[7] recommended that close scrutiny of cellular atypia or hyperplasia in cases of endometriosis be applied to determine increased risk of concurrent or subsequent malignancy in the ovarian and extra-ovarian sites.”
BackgroundAlduaij, A., Hansen, K., Karim, T. A., et al. (2012) · Pathology Research International · doi:10.1155/2012/674748 · Cited by 7
“Ovarian CCCs are often associated with endometriosis, and an association with atypical endometriosis is documented [19].”
BackgroundResultMalpica, A. L., Euscher, E. D., Ramalingam, P., et al. (2020) · Springer eBooks · doi:10.1007/978-3-319-96681-6_15 · Cited by 7
Sato, S., Itamochi, H., Oumi, N., Chiba, Y., Oishi, T., Shimada, M., Sato, S., Chikumi, J., Nonaka, M., Kudoh, A., et al. (2016) · Human Cell · doi:10.1007/s13577-016-0138-6 · Cited by 6
Endometriosis and Ovarian Cancer: From Molecular Evidences to Clinical Implications
Filho, A. L. D. S., Ferreira, M. C. F., Lamaita, R. M., Rocha, A. L. L., Cândido, E. B., & Carneiro, M. M. (2015) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000248 · Cited by 6
“Differently, atypia has been demonstrated more frequently in endometriosis patients who present ovarian cancer (35-37).”
BackgroundEndometriosis: A Malignant Fingerprint
DeAngelo, C., Tarasiewicz, M. E. B., Strother, A. M., Taggart, H., Gray, C. J., Shanahan, M., Glowacki, C., Khandalavala, J., Talaska, E., Kinnan, A., et al. (2020) · Journal of Cancer Research and Therapeutic Oncology · doi:10.17303/jcrto.2020.8.206 · Cited by 6
“The use of CA125 as a potential biomarker for EAOC is limited as this subtype of ovarian cancer may not result in CA-125 elevations [78].”
BackgroundInfluentialMature cystic teratoma coexisting with clear‐cell carcinoma in the ovary
Shimura, K., Matsumoto, M., Sugahara, T., et al. (2016) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13224 · Cited by 6
How Benign is Endometriosis: Multi-Scale Interrogation of Documented Evidence
Ghosh, D., Geethadevi, A., Bhat, M. A., Bharti, J. N., Mridha, A., Jb, S., Kk, R., & Sengupta, J. (2019) · Current Opinion in Gynecology and Obstetrics · doi:10.18314/cogo.v2i1.1840 · Cited by 6
“The incidence of AE in OC reportedly ranged from 4-23% [56-61].”
BackgroundIrving, J. A., & Clement, P. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_13 · Cited by 6
Atypical endometriosis: a clinicopathologic study of 163 cases
Guo, D., Pang, S., & Shen, Y. (2007) · Chinese Journal of Clinical Oncology · doi:10.1007/s11805-007-0405-0 · Cited by 6
Morules with optically clear nuclei in ovarian borderline endometrioid tumor
Li, C. C., Hirokawa, M., Qian, Z., et al. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1101103.x · Cited by 6
“This is not surprising since an origin from endometriosis is only demonstrable in some endometrioid tumors, and is not required for the diagnosis (2,3,4).”
BackgroundHyperplasias of the Endometrium
Wells, M. L. (2004) · Gynecologic Cancer · doi:10.1016/b978-0-443-07142-3.50022-1 · Cited by 6
Suzuki, H., Yano, M., Miyazawa, M., et al. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0481-9 · Cited by 5
The Pathology of Pelvic-Ovarian Epithelial (Epithelial-Stromal) Tumors
Howitt, B. E., Lee, K. R. C. K., Muto, M. G., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-44732-4.00025-x · Cited by 5
Extragonadal giant endometrial cyst with endometrioid borderline tumor
Yazawa, H., Imaizumi, K., Kato, A., & Takiguchi, K. (2019) · Gynecology and Minimally Invasive Therapy · doi:10.4103/gmit.gmit_85_18 · Cited by 4
“183 Gynecology and Minimally Invasive Therapy ¦ October-December 2019 ¦ Volume 8 ¦ Issue 4 in 67% of cases of CCC and 54% of cases of endometrioid carcinoma among 27 and 13 cases of ERONs, respectively.[30] Ogawa et al.”
BackgroundThe Association of Endometriosis with Ovarian Cancer: A Critical Review of Epidemiological Data
Guo, S. (2014) · Springer eBooks · doi:10.1007/978-4-431-54421-0_22 · Cited by 4
Ray, L. J., & Watkins, J. C. (2023) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2023.07.003 · Cited by 4
Borghese, B., Santulli, P., Vaiman, D., Alexandre, J., Goldwasser, F., & Chapron, C. (2013) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2013.02.013 · Cited by 4
Endométriose extraovarienne dégénérée : à propos de trois cas et revue de la littérature
Benoît, L., Arnould, L., Margarot, A., Franceschini, C., Collin, F., Fraisse, J., & Cuisenier, J. (2004) · Annales de Chirurgie · doi:10.1016/j.anchir.2004.04.014 · Cited by 4
“L’hypothèse d’une dégénérescence sur endométriose est longtemps restée débattue même si la découverte fréquente d’atypies cellulaires sur endométriose au voisinage des carcinomes plaiderait en sa faveur [8].”
BackgroundEpigenetic control of endocrine disrupting chemicals on gynecological disease: Focused on phthalates
Cho, H. H. (2012) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2012.55.9.619 · Cited by 4
“자궁 내막증이 있던 환자에서 발생하는 난소암은 특별한 조직형을 보이는 데, Fukunaga 등[47]은 40% 이상이 투명세포(clear cell) 및 자궁내막 모양세포(endometrioid)이며 일반 난소암과 자궁내막모양세포암은 서 로 다른 발생기전을 갖는다고 주장한 바 있다.”
Ichigo, S., Takagi, H., Matsunami, K., Murase, T., Ikeda, T., & Imai, A. (2014) · Journal of Gynecologic Surgery · doi:10.1089/gyn.2013.0089 · Cited by 4
Kiyokawa, T. (2022) · Surgical pathology clinics · doi:10.1016/j.path.2022.02.005 · Cited by 3
Zhang, X., Wang, L., Ruan, X., Ding, J., Wan, J., Xu, C., & Li, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-03387-1 · Cited by 3
“Mounting evidence indicates that endometriosis foci exhibiting cellular or structural heterogeneity can be identified through prospective follow-up or systematic histological review of endometriosis-associated ovarian cancer cases [30–33].”
The Pathology of Pelvic-Ovarian Epithelial (Epithelial-Stromal) Tumors
Nucci, M. R., Crum, C. P., & Lee, K. R. C. K. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0764-9.00027-5 · Cited by 3
The many faces of endometriosis
de Souza, M. L. P., da Costa, T. P., de Freitas, N. P., de Souza, M. F., & Athanazio, D. A. (2022) · Autopsy and Case Reports · doi:10.4322/acr.2021.409 · Cited by 3
Шилина, М. А., Domnina, A. P., Kozhukharova, I. V., Zenin, V. V., Anisimov, S. V., Nikolsky, N. N., & Гринчук, Т. М. (2016) · Cell and Tissue Biology · doi:10.1134/s1990519x16010107 · Cited by 3
Ormsby, E. L., Pavlik, E. J., & McGahan, J. P. (2017) · Diagnostics · doi:10.3390/diagnostics7020025 · Cited by 3
Sarmadi, S., Izadi‐Mood, N., Hajeer, P., et al. (2018) · International Journal of Cancer Management · doi:10.5812/ijcm.9610 · Cited by 3
“A transition point from an endometriotic lesion (atypical endometriosis) to a frankly ovarian invasive carcinoma has been demonstrated in 36% to 42% of cases (19-24).”
Background(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00031-3 · Cited by 3
Piacenti, I., Tius, V., Gomba, B., Restaino, S., Arcieri, M., Zermano, S., Biasioli, A., Perelli, F., Raimondo, D., Lazzeri, L., et al. (2026) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2026.04.021 · Cited by 3
Maggiore, U. L. R., Vignali, M., Kvaskoff, M., Chiappa, V., Somigliana, E., Vercellini, P., Raspagliesi, F., & Viganò, P. (2026) · Human Reproduction Update · doi:10.1093/humupd/dmag011 · Cited by 4
Watkins, J. C., Nascimento, A. F., & Nucci, M. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-44732-4.00023-6 · Cited by 2
Endometriosis and Endometriosis-Associated Tumors
Simmen, R. C. M., Quick, C. M., & Zheng, W. (2024) · Springer eBooks · doi:10.1007/978-981-19-7696-4_12-1 · Cited by 2
Liu, C., Chen, P., Yang, Z., Zhang, K., Chen, F., Zhu, Y., Liu, J., Liu, L., Wang, D., & Wang, D. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104326 · Cited by 2
Malignant transformation of persistent endometriosis after hysterectomy
Bawazeer, N. A., Al-Jifree, H., & Gari, A. M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6084 · Cited by 2
Endometriosis-Associated Ovarian Cancer: The Role of Oxidative Stress
Yamashita, Y., & Toyokuni, S. (2012) · InTech eBooks · doi:10.5772/30541 · Cited by 2
Tumores Ováricos Borderline (de Bajo Potencial de Malignidad)
de Losada, J. P. D. (2007) · Revista Española de Patología · doi:10.1016/s1699-8855(07)70080-6 · Cited by 2
“La endometriosis atípica ipsilateral podría participar en el proceso de transformación maligna (82).”
BackgroundMultiple Synchronous Primary Gynecologic Malignancies in an MSH2 Mutation Carrier With Endometriosis
Shoni, M., Parra‐Herran, C., May, T., Wright, A. A., & Feltmate, C. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4274 · Cited by 2
Atypical Ovarian Endometriosis
Fukunaga, M. (2006) · Pathology Case Reviews · doi:10.1097/01.pcr.0000196558.69330.30 · Cited by 2
Self-citationSpontaneously Ruptured Endometrioma Associated with Endometrioid Adenocarcinoma: MR Findings
Kozawa, E., Matsuo, Y., Hasegawa, K., et al. (2010) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.9.233 · Cited by 2
A Case of Rectal Endometriosis with Regional Lymph Node Involvement
HIRAU, K., Hashimoto, M., Hirano, Y., Sasaki, S., Nakamura, M., & Nakatsu, T. (2013) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.74.1326 · Cited by 2
Oxidative Stress and its Role in Endometriosis—Mechanistic and Therapeutic Implications
Agarwal, A. K., Gupta, S., Shenoy, R., Safi, J., & Gaglani, A. (2012) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/11630_37 · Cited by 2
Premalignant disease of the genital tract
Moss, E., Redman, C. W. E., & Ganesan, R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3120-5.00038-2 · Cited by 2
Morphological and Molecular Pathogenesis of Epithelial Ovarian Tumors
Tashiro, H., Imamura, Y., Motohara, T., Sakaguchi, I., & Katabuchi, H. (2017) · Comprehensive gynecology and obstetrics · doi:10.1007/978-981-10-4160-0_3 · Cited by 2
Recent Advances in Molecular Genetics of Endometriosis
Silveira, C. G. T., Rogatto, S. R., Podgaec, S., & Abrão, M. S. (2009) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/228402650900100103 · Cited by 2
“Specifically in the case of ovarian cancer, endometriosis is considered a significant risk factor and epidemiological data indicate that the incidence of endometriosis in women with ovarian cancer ranges from 8 to 30% (78, 96, 97).”
BackgroundEndometriosis-Associated Ovarian Carcinoma
Păvăleanu, I., Balan, T. A., Poparlan, T. N., Haliciu, A. M., Buţureanu, T., Apetrei, A. M., Socolov, R. V., Pruteanu, A. I., & Balan, R. A. (2024) · Obstetrics and gynecology. · doi:10.5772/intechopen.1007677 · Cited by 1
Recent advances in molecular genetics of endometriosis
Silveira, C. G. T., Rogatto, S. R., Podgaec, S., & Abrão, M. S. (2009) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.2009.1980 · Cited by 1
Endometriosis and Ovarian Cancer
Gupta, S., Harlev, A., Agarwal, A. K., Gupta, A. K., Gray, M., Solvik, K., & DeLeonibus, M. (2015) · SpringerBriefs in reproductive biology · doi:10.1007/978-3-319-18308-4_7 · Cited by 1
Pathology of Endometriosis and Lesions of the Secondary Müllerian System
Clement, P. B., & Young, R. H. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2972-4.50023-4 · Cited by 1
Ovarian endometrioid, clear cell, Brenner, and rare epithelial–stromal tumors
Prat, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-07477-6.50030-5 · Cited by 1
Distribution of malignant neoplasms among patients with endometriosis: an epidemiological study
Байрамова, Н. Н., Protasova, A. E., Раскин, Г. А., Yarmolinskaya, M. I., Tsypurdeyeva, A. A., & Gavrilova, M. D. (2018) · Journal of obstetrics and women s diseases · doi:10.17816/jowd6765-12 · Cited by 1
“На сегодняшний день атипический эндометриоз рассматривается как морфологическая форма предрака ЭОАЯ [7, 19, 20].”
Widyawati, R., Siregar, B., & Kusmardi, K. (2019) · AIP conference proceedings · doi:10.1063/1.5139372 · Cited by 1
Tomita, S. A., Mehrotra, M., Chaoul, J., Houldsworth, J., Kolev, V., & Kalir, T. (2021) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2021.100718 · Cited by 1
Diagnostic Benefit of the Detection of Mitotic Figures in Endometriotic Lesions
Wetzk, M., Grübling, N., Forberger, A., Klengel, J., Kuhlmann, J. D., Wimberger, P., & Goeckenjan, M. (2022) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1580-0601 · Cited by 1
“Atypical ovarian endometriosis is known to be especially associated with an increased risk of malignancy [13].”
Soslow, R. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-35909-2.00018-7 · Cited by 1
Molecular Pathogenesis of Ovarian Cancer: An Inextricable Maze
Mandai, M. (2018) · Springer eBooks · doi:10.1007/978-981-10-7941-2_10 · Cited by 1
Ovarian Carcinoma Associated with Endometriosis
Yasuda, M., & Yano, M. (2018) · Springer eBooks · doi:10.1007/978-981-10-8606-9_5 · Cited by 1
Euscher, E. D., & Wei, J. (2021) · Pracatical anatomic pathology · doi:10.1007/978-3-030-68608-6_9 · Cited by 1
Endometriosis and Cancer: Epidemiology
Viganò, P., Somigliana, E., Parazzini, F., & Vercellini, P. (2011) · doi:10.1002/9781444398519.ch49 · Cited by 1
Pathophysiological factors and genetic association in endometriosis
Sundqvist, J. (2011) · Figshare · Cited by 1
Coexisting clear cell adenocarcinoma and squamous cell carcinoma arising from ovarian endometriosis
Jobo, T., Kawaguchi, M., Imai, M., et al. (2000) · International Journal of Clinical Oncology · doi:10.1007/pl00012071 · Cited by 1
“Fukunaga et al.5 reported that 18 of 50 cases of ovarian clear cell carcinoma coexisted with atypical endometriosis, and in 7 cases, the atypical endometriosis was in contiguity with the malignant epithelial tumor.”
BackgroundDeFrias, D. V. S., Okonkwo, A. M., Keh, P. C., et al. (2002) · Springer eBooks · doi:10.1007/978-1-4757-3587-1_8 · Cited by 1
Cancers ovariens au stade I: deux carcinogenèses différentes ?
Deligdisch, L. (2007) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32922-x · Cited by 1
The emerging role of epigenetics in the aetiology of endometriosis.
Rosser, M. (2011) · DMU Open Research Archive (De Montfort University)
Endometriosis and Cancer: Is There an Association?
Vega, M. G., Soto, E., & Goldberg, J. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17849-3_5
Malignant Transformation of Endometriosis: Underlying Mechanisms
Mandai, M., Yamaguchi, K. D., Matsumura, N., & Konishi, I. (2014) · Springer eBooks · doi:10.1007/978-4-431-54421-0_15
Characterization of Iron Response in Gynecological Cell Lines
Bauckman, K. (2014) · Digital Commons - University of South Florida (University of South Florida)
Yarmohamadi, A., & Mogharabi, N. (2012) · InTech eBooks · doi:10.5772/36774
Endometriosis‐Associated Ovarian Cancer
Garrett, L. A., & Carmen, M. G. D. (2014) · doi:10.1002/9781118655344.ch8
Fagotti, A., Garganese, G., Fanfani, F., et al. (2005) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)
An investigation of basic science and clinical research methodologies to benefit clinical practice
Varma, R. (2009) · University of Birmingham Institutional Research Archive (University of Birmingham)
Pathogenesis of the Endometriosis-Related Ovarian Neoplasms
Maeda, D. (2014) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-013-0073-4
“Furthermore, atypical endometriosis is reported to be found in 23 % of ECs [8].”
BackgroundHayashi, M., Shoda, A., Kosaka, N., Kojima, M., Masawa, N., & Fukasawa, I. (2013) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2013.37100
“Atypical endometriosis is supposed to be closely associated with the development of endometrioid adenocarcinoma in malignant transformation of ovarian endometriosis [16,17].”
BackgroundAmemiya, S., Sekizawa, A., Otsuka, J., Okuda, T., Akahane, T., Kushima, M., Tachikawa, T., Saito, H., & Okai, T. (2004) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms1989.16.47
Tsugata, M. (2007) · Institutional Repositories DataBase (IRDB) · doi:10.11480/jmds.540302
Metadata
- Authors
- FUKUNAGA, M., NOMURA, K., ISHIKAWA, E., & USHIGOME, S.
- Affiliations
- Jikei University School of Medicine (JP)
- Corresponding author
- FUKUNAGA, M.
- ORCID
- FUKUNAGA, M.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 1997-03
- Volume
- 30
- Issue
- 3
- Pages
- 249-255
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2084264037
- Cited by
- 333
- References
- 0
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 11 · 2023: 9 · 2022: 9 · 2021: 11 · 2020: 13 · 2019: 14 · 2018: 19 · 2017: 8 · 2016: 10 · 2015: 17 · 2014: 17 · 2013: 14 · 2012: 22
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Histopathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- endometrioma, endometrioid carcinoma, clear cell carcinoma, ovarian cancer, serous carcinoma, serous borderline tumor, long-term follow-up
- MeSH terms
- Adult, Carcinoma, Endometriosis, Female, Humans, Middle Aged, Ovarian Diseases, Ovarian Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review